Research ArticleArticle
Monophasic Disease Course in Systemic Lupus Erythematosus
Konstantinos Tselios, Dafna D. Gladman, Zahi Touma, Jiandong Su, Nicole Anderson and Murray B. Urowitz
The Journal of Rheumatology June 2018, jrheum.171319; DOI: https://doi.org/10.3899/jrheum.171319
Konstantinos Tselios
From the Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network, Toronto, Ontario, Canada. The University of Toronto Lupus Research Program is supported by Lou and Marissa Rocca, Lupus Canada, and the Canadian Institute of Health Research [Competition No 201610PJT, Application No. 377979]. K. Tselios, MD, PhD, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network; D.D. Gladman, MD, FRCPC, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network; Z. Touma, MD, FACP, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network; J. Su, MB, MSc, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network; N. Anderson, HBSc, CCRP, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network; M.B. Urowitz, MD, FRCPC, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network. Address correspondence to Dr. M.B. Urowitz, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, 399 Bathurst St., 1E-410B, Toronto, Ontario M5T 2S8, Canada. E-mail: m.urowitz@utoronto.ca. Accepted for publication February 28, 2018.
Dafna D. Gladman
From the Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network, Toronto, Ontario, Canada. The University of Toronto Lupus Research Program is supported by Lou and Marissa Rocca, Lupus Canada, and the Canadian Institute of Health Research [Competition No 201610PJT, Application No. 377979]. K. Tselios, MD, PhD, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network; D.D. Gladman, MD, FRCPC, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network; Z. Touma, MD, FACP, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network; J. Su, MB, MSc, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network; N. Anderson, HBSc, CCRP, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network; M.B. Urowitz, MD, FRCPC, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network. Address correspondence to Dr. M.B. Urowitz, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, 399 Bathurst St., 1E-410B, Toronto, Ontario M5T 2S8, Canada. E-mail: m.urowitz@utoronto.ca. Accepted for publication February 28, 2018.
Zahi Touma
From the Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network, Toronto, Ontario, Canada. The University of Toronto Lupus Research Program is supported by Lou and Marissa Rocca, Lupus Canada, and the Canadian Institute of Health Research [Competition No 201610PJT, Application No. 377979]. K. Tselios, MD, PhD, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network; D.D. Gladman, MD, FRCPC, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network; Z. Touma, MD, FACP, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network; J. Su, MB, MSc, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network; N. Anderson, HBSc, CCRP, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network; M.B. Urowitz, MD, FRCPC, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network. Address correspondence to Dr. M.B. Urowitz, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, 399 Bathurst St., 1E-410B, Toronto, Ontario M5T 2S8, Canada. E-mail: m.urowitz@utoronto.ca. Accepted for publication February 28, 2018.
Jiandong Su
From the Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network, Toronto, Ontario, Canada. The University of Toronto Lupus Research Program is supported by Lou and Marissa Rocca, Lupus Canada, and the Canadian Institute of Health Research [Competition No 201610PJT, Application No. 377979]. K. Tselios, MD, PhD, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network; D.D. Gladman, MD, FRCPC, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network; Z. Touma, MD, FACP, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network; J. Su, MB, MSc, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network; N. Anderson, HBSc, CCRP, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network; M.B. Urowitz, MD, FRCPC, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network. Address correspondence to Dr. M.B. Urowitz, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, 399 Bathurst St., 1E-410B, Toronto, Ontario M5T 2S8, Canada. E-mail: m.urowitz@utoronto.ca. Accepted for publication February 28, 2018.
Nicole Anderson
From the Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network, Toronto, Ontario, Canada. The University of Toronto Lupus Research Program is supported by Lou and Marissa Rocca, Lupus Canada, and the Canadian Institute of Health Research [Competition No 201610PJT, Application No. 377979]. K. Tselios, MD, PhD, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network; D.D. Gladman, MD, FRCPC, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network; Z. Touma, MD, FACP, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network; J. Su, MB, MSc, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network; N. Anderson, HBSc, CCRP, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network; M.B. Urowitz, MD, FRCPC, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network. Address correspondence to Dr. M.B. Urowitz, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, 399 Bathurst St., 1E-410B, Toronto, Ontario M5T 2S8, Canada. E-mail: m.urowitz@utoronto.ca. Accepted for publication February 28, 2018.
Murray B. Urowitz
From the Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network, Toronto, Ontario, Canada. The University of Toronto Lupus Research Program is supported by Lou and Marissa Rocca, Lupus Canada, and the Canadian Institute of Health Research [Competition No 201610PJT, Application No. 377979]. K. Tselios, MD, PhD, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network; D.D. Gladman, MD, FRCPC, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network; Z. Touma, MD, FACP, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network; J. Su, MB, MSc, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network; N. Anderson, HBSc, CCRP, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network; M.B. Urowitz, MD, FRCPC, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network. Address correspondence to Dr. M.B. Urowitz, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, 399 Bathurst St., 1E-410B, Toronto, Ontario M5T 2S8, Canada. E-mail: m.urowitz@utoronto.ca. Accepted for publication February 28, 2018.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Monophasic Disease Course in Systemic Lupus Erythematosus
Konstantinos Tselios, Dafna D. Gladman, Zahi Touma, Jiandong Su, Nicole Anderson, Murray B. Urowitz
The Journal of Rheumatology Jun 2018, jrheum.171319; DOI: 10.3899/jrheum.171319